Aclaris Therapeutics, Inc. (ACRS)

PriceLoading quote

Financial charts

Revenue

Net income

Free cash flow

Total cash / debt

CashTotal debt

Financial statements

13 annual periodsNewest to oldest
2025202420232022202120202019201820172016201520142013
Revenue$7.8M$18.7M$31.2M$29.8M$6.8M$6.5M$4.2M$6.2M$1.7M
Gross profit$3.2M$476,000
Research & development$52.6M$33.6M$98.4M$77.8M$43.8M$29.3M$64.2M$60.8M$35.8M$33.5M$15.3M$6.5M$3.5M
Operating expenses$138.7M$72.9M$48.6M$20.7M$8.5M$5.3M
Operating income−$76.4M−$141.9M−$97.4M−$89.9M−$89.7M−$50.9M−$111.1M−$84.8M−$54.4M−$48.6M−$20.7M−$8.5M−$5.3M
EBITDAderived−$75.9M−$141.1M−$96.5M−$89.1M−$88.8M−$49.6M−$104.6M−$82.9M−$54.0M−$48.4M−$20.6M
Net income−$64.9M−$132.1M−$88.5M−$86.9M−$90.9M−$51.0M−$161.4M−$132.7M−$68.5M−$48.1M−$20.6M−$8.5M−$5.2M
Basic EPSper diluted share-$0.53-$1.71-$1.27-$1.33-$1.60-$1.20-$3.90-$4.03-$2.44-$2.25-$3.79-$6.15-$6.45
Diluted EPSper diluted share-$0.53-$1.71-$1.27-$1.33-$1.60-$1.20-$3.90-$4.03-$2.44-$2.25-$3.79-$6.15-$6.45

Insider buys & sells

Jul 1, 2024Jun 30, 2026
Buys15$4.68M disclosed value
Sells (SEC code S)1$1.36M disclosed value
16 recent transactions
TransactionInsiderTypeSharesPriceValueOwned after
Apr 23, 2026Form 4Leonard Braden MichaelTenPercentOwnerSellCommon Stock · indirect300.0K$4.53$1.36M13.95M
Nov 19, 2024Form 4Mehra AnandDirectorBuyCommon Stock666.7K$2.25$1.50M710.0K
Aug 5, 2024Form 4Leonard Braden MichaelTenPercentOwnerBuyCommon Stock · indirect206.0K$1.24$255.5K14.25M
Aug 2, 2024Form 4Leonard Braden MichaelTenPercentOwnerBuyCommon Stock · indirect167.5K$1.29$216.1K14.04M
Jul 31, 2024Form 4Leonard Braden MichaelTenPercentOwnerBuyCommon Stock · indirect100.0K$1.33$133.0K13.88M